Description: The Predictive Analytics Seminar is a unique event that allows experts in the practice areas of life, health, and P&C to come together and explore the vast world of predictive analytics.

Description: The Introduction to ILA module will explore topics including insurance products, financial reporting, reserving, distribution and administration.

Description: Asset liability management is an important task for any insurer, where tools like Excel play an important role from an analytics perspective. Dashboard tools like Power Bi and Tableau can supercharge an organization’s ability to perform ALM with real-time precision and monitoring of risk/imbalances. The dashboard can provide insights into potential risks posed by asset allocation and concentration, allowing for informed decision-making to mitigate those risks. The presenters will walk the audience through an example of ALM use case, including how to build key performance indicators such as cash flow, asset allocation, and risk exposure. Additionally, we will demonstrate how these types of dashboards can be customized to fit the specific needs of your organization.

Description: Join the IAJ (the Institute of Actuaries of Japan) as they deep dive the Japan mortality and morbidity trend impacted by COVID-19. During COVID-19, Japan experienced increasing COVID-19 patients and deteriorated morbidity trend mainly due to deemed hospitalization. This was introduced to regard the treatment under the doctors' supervision outside of the hospital as hospitalization, given shortage of hospital beds, and add accident death benefit payment triggered by COVID-19. Expect coverage on the mortality/morbidity analysis comparison in Japan, US and globally, as well as comprehensively discuss how Japanese insurers identified solutions to respond to the changing market. Also, you'll discuss consumers' needs and how more uncertainty drives them to prepare individual lifetime retirement income.

Description: Mortality Improvement is fundamental to setting your mortality assumptions. Creating your own Mortality Improvement assumption may seem like a Herculean task. The truth is creating a mortality improvement assumption with tools provided by the SOA, or the Continuous Mortality Investigation (CMI) make the process easy. Leaving you with the Herculean task of deciding if the assumption you created fits your product. Expect to learn about the CMI tool and the SOA's Mortality Improvement Model (MIM) tool, how you might get data to use in those tools, and what assumptions you need to make outside of data like what will the MI be in 20 or 30 years? Whether it is the general population, a segment of the general population, or certain causes of death, you will get very different answers.

Description: Broaden your understanding of how long-term care (LTC) is provided and brainstorm with other actuaries on ways to help society fund future LTC solutions. How we fund and provide LTC for our loved ones has changed over time and will evolve still by the time we retire. In this session we will explore the variety of ways that we fund LTC services: out of pocket and with informal care, Medicaid, lifeplan communities (Continuing Care Retirement Communities and and the Continuing Care at Home model), private LTC insurance and more. You will leave the session appreciating that providing long-term care is a key feature of our aging society and understand the variety of ways that we fund LTC today and may in the future.

Description: Expect to learn how recent advances in AI and Generative text technology can help unlock data from medical records to solve many key underwriting and actuarial challenges. Specific topics include the following: - What is NLP/AI/machine learning and how is it currently being used in underwriting? - What technological advancements have Insure Techs made in the use of AI and GPT, and how are carriers/reinsurers utilizing these enhancements? - How can you avoid some of the challenges with GPT such as Hallucinations and 'black box' outputs? - How can extraction of data from medical records assist actuaries with various pricing and analysis challenges? - What legal/compliance challenges should users be aware of and how to manage those risks?

Description: As more gene and cell therapies enter the market at increasingly higher price points, they are ushering in a new era of medicine for rare diseases. Unlike most traditional therapies, gene and cell therapies typically have a short or one-time treatment administration and are anticipated to provide long-term clinical benefits. Actuaries must be prepared to assess, manage, and/or mitigate the risks associated with these therapies. This session includes three different perspectives—a regional plan, a stop loss/reinsurance carrier, and a health care consultant.

Description: CMS launched the value-based insurance design (VBID) model in 2017, allowing health plans to offer innovative supplemental benefits and incentives to beneficiaries to use high-value services specific to their health care needs or socioeconomic position. CMS's stated goal is to encourage health plans to implement strategies that focus on health equity. The model has evolved over time and has grown tremendously in popularity over the years since it was introduced.

Description: Given the rise in interest rates during 2022, join an insightful discussion on the implications of increasing rates on fixed annuity (FA) and fixed index annuity (FIA) business by looking at industry experience for FA and FIA products for 2022 compared to earlier years. Additionally, you will walk through partial withdrawals, guaranteed lifetime withdrawal benefit (GLWB) utilization, mortality and what to expect as interest rate volatility continues.